Tolerance of a short course of nevirapine, associated with 2 nucleoside analogues, in postexposure prophylaxis of HIV

Authors :: Rey, David
Partisani, Marialuisa
Hess-Kempf, Georgette
Krantz, Veronique
Priester, Michele
Lang, Jean-Marie
Decroix, Laetitia
Mautort, Erik de
Bernard-Henry, Claudine
Cheneau, Christine
Source :: Journal of Acquired Immune Deficiency Syndromes (1999). Dec 1, 2004, Vol. 37 Issue 4, p1454, 3 p.
Publication Year :: 2004
Abstract: A study was conducted with the aim of evaluating the tolerance of all nevirapine (NVP) containing postexposure prophylaxis (PEP) treatments prescribed during a 2-year period. The study gave evidence to believe that a short course of 200-mg NVP treatment once a day in combination with nucleoside analogues for one month is clinically and biologically safe.

Subjects :: HIV infection -- Drug therapy
HIV infection -- Research
Nevirapine -- Dosage and administration
Nevirapine -- Research
Health

Tools